在接受已故捐赠者移植的七十多岁人群中,Alemtuzumab的诱导
David I Harriman1, Alex Ng1, Alan C Farney2
1Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Clinical transplantation
|March 5, 2026
概括
在老年脏移植接受者中,子抗胆小细胞球蛋白 (ATG) 显示出比阿勒姆图祖马布更好的生存结果. 在七十多岁的已故捐赠者移植患者中,ATG可能会优先于阿勒姆图祖马布.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 抗CD52单克隆抗体Alemtuzumab用于移植 (KT) 的诱导.
- 它在七十多岁的接受者中使用的研究不足.
- 这项研究重点关注单剂量阿勒姆图祖马布在该人群中的安全性和有效性.
研究的目的:
- 分析单剂量阿勒姆图祖马布诱导在七十多岁的已故捐赠者 (DD) KT接受者的安全性和有效性.
- 为了比较阿勒姆图祖马布与多剂量子抗胆小细胞球蛋白 (ATG) 诱导.
主要方法:
- 七十多岁的DDKT接受者的回顾性队列审查.
- 基于诱导免疫抑制的分层:单剂量阿勒姆图祖马布与多剂量ATG.
- 标准化维护免疫抑制:塔克罗利/酸/类固醇.
主要成果:
- 分析了359个DDKTs (阿勒姆图祖马布n=270,ATGn=89).
- 五年移植存活率偏好ATG (74.7%) 超过阿勒姆图祖马布 (60.2%,p=0.04).
- 患者的存活率也有利于ATG (82.9%) 超过阿勒姆图祖马布 (70.3%,p=0.054).
结论:
- 在七十多岁的DDKT接受者中,ATG诱导与优越的生存结果有关.
- 在这个人口群体中,ATG可能是首选的诱导剂,而不是阿勒姆图祖马布.
- 在三重维持治疗的老年KT患者使用阿勒姆图祖马布时,建议谨慎使用.
相关概念视频
01:28Kidney Transplant I: Introduction
606
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
606
01:26Kidney Transplant II: Surgical Procedure
592
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
592
01:22Bone Marrow Sampling and Transplants
2.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.0K